DR.Chip Biotechnology Incorporation announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 25.857 million compared to TWD 25.984 million a year ago. Operating loss was TWD 5.517 million compared to TWD 3.375 million a year ago. Net loss was TWD 4.701 million compared to net income of TWD 2.608 million a year ago. Basic loss per share was TWD 0.09 compared to basic earnings per share of TWD 0.05 a year ago. For the nine months, sales was TWD 69.610 million compared to TWD 77.629 million a year ago. Operating loss was TWD 23.060 million compared to TWD 13.617 million a year ago. Net loss was TWD 19.970 million compared to TWD 4.328 million a year ago. Basic loss per share was TWD 0.41 compared to TWD 0.09 a year ago.